These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 19195684)

  • 1. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.
    Ban-Hoefen M; Francis C
    Thromb Res; 2009 Jun; 124(2):189-92. PubMed ID: 19195684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
    Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
    Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.
    Baroletti S; Piovella C; Fanikos J; Labreche M; Lin J; Goldhaber SZ
    Thromb Haemost; 2008 Dec; 100(6):1130-5. PubMed ID: 19132240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of consecutive repeat HIT ELISA testing for heparin-induced thrombocytopenia.
    Chan M; Malynn E; Shaz B; Uhl L
    Am J Hematol; 2008 Mar; 83(3):212-7. PubMed ID: 17910041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia after liver transplantation.
    Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Makuuchi M
    Transplant Proc; 2008 Jun; 40(5):1518-21. PubMed ID: 18589141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
    Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
    Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.
    Warkentin TE; Roberts RS; Hirsh J; Kelton JG
    Arch Intern Med; 2003 Nov; 163(20):2518-24. PubMed ID: 14609790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
    ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
    Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis.
    Alving BM; Krishnamurti C
    Semin Thromb Hemost; 1997; 23(6):569-74. PubMed ID: 9469632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.
    Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
    Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
    Menajovsky LB
    Am J Med; 2005 Aug; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?
    Lubenow N; Hinz P; Ekkernkamp A; Greinacher A
    Eur J Haematol; 2007 Sep; 79(3):187-90. PubMed ID: 17655709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher optical density of an antigen assay predicts thrombosis in patients with heparin-induced thrombocytopenia.
    Altuntas F; Matevosyan K; Burner J; Shen YM; Sarode R
    Eur J Haematol; 2008 May; 80(5):429-35. PubMed ID: 18208574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heparin-induced thrombocytopenia: report of four cases in severely burned patients].
    Bargues L; Foissaud V; Jault P; Samson T; Carsin H
    Ann Fr Anesth Reanim; 2006; 25(11-12):1135-9. PubMed ID: 17034986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].
    Franke J; Schaeper O; Kayser R; Mahlfeld K
    Unfallchirurg; 2003 Jan; 106(1):77-81. PubMed ID: 12552397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
    Pohl C; Kredteck A; Bastians B; Hanfland P; Klockgether T; Harbrecht U
    Neurology; 2005 Apr; 64(7):1285-7. PubMed ID: 15824368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation of heparin-induced thrombocytopenia.
    Warkentin TE
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):9-16; discussion 35-6. PubMed ID: 9855179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory tests for the diagnosis of heparin-induced thrombocytopenia.
    Walenga JM; Jeske WP; Fasanella AR; Wood JJ; Bakhos M
    Semin Thromb Hemost; 1999; 25 Suppl 1():43-9. PubMed ID: 10357151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin-induced thrombocytopenia syndrome and thrombosis in patients undergoing periodic haemodialysis].
    Gregorini G; Bellandi D; Martini G; Volpi R
    G Ital Nefrol; 2002; 19(6):672-92. PubMed ID: 12508172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.